Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 809, pseudogene (RN7SL809P) is a **pseudogene** variant of the 7SL RNA family found dispersed within the human genome[6][7]. The canonical 7SL RNA is a highly conserved noncoding RNA component of the signal recognition particle (SRP) ribonucleoprotein complex, which is essential for targeting newly synthesized proteins to cellular membranes[1]. However, RN7SL809P does not encode a functional RNA, and instead, like other 7SL RNA pseudogenes, arises from the reverse integration of 7SL RNA into genomic DNA[5][7]. Most 7SL pseudogenes are truncated, nonfunctional fragments and do not produce protein or functional RNA. Although some pseudogenes in general may play regulatory roles in gene expression or miRNA signaling, there is no specific evidence associating **RN7SL809P** with therapeutic, diagnostic, or disease-modifying functions as a molecular target[3][4][7].
Not applicable (no drugs directly target this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 809, pseudogene (RN7SL809P).